AUM$10.3M
Expense Ratio0.75%
NAV$23.37
Holdings4
InceptionJan 22, 2024
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
$20.12$24.55
Avg Volume
—Dividend Yield
—Expense Ratio
0.75%AUM
$10.3MShares Outstanding
—Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 74.62% |
| Ireland | 6.42% |
| Netherlands | 5.83% |
| Israel | 4.32% |
| Belgium | 2.48% |
| Other | 2.08% |
| Canada | 1.81% |
| Germany | 1.30% |
| Finland | 1.14% |
Fund Information
- Issuer
- Tema
- Category
- Healthcare
- Inception Date
- Jan 22, 2024
- Description
- The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. The fund is designed to capitalize on innovation in treatments for CNS diseases.
Similar ETFs
The Tema Neuroscience And Mental Health ETF (MNTL) is an exchange-traded fund issued by Tema that launched on Jan 22, 2024. It currently manages $10.3M in assets under management. The fund charges an expense ratio of 0.75%. The fund holds 4 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 55.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS, INC. | 10.33% | 2,298 | $1.1M |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 8.09% | 1,488 | $832K |
| 3 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 7.74% | 1,982 | $796K |
| 4 | ARGX | ARGENX SE | 5.83% | 890 | $600K |
| 5 | NBIX | NEUROCRINE BIOSCIENCES, INC. | 4.89% | 3,904 | $503K |
| 6 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD. | 4.32% | 28,861 | $444K |
| 7 | LLY | ELI LILLY & CO. | 4.05% | 547 | $417K |
| 8 | CRNX | CRINETICS PHARMACEUTICALS, INC. | 3.54% | 13,066 | $364K |
| 9 | IONS | IONIS PHARMACEUTICALS, INC. | 3.48% | 8,318 | $358K |
| 10 | SYK | STRYKER CORP. | 3.22% | 877 | $331K |
| 11 | BIIB | BIOGEN, INC. | 3.21% | 2,501 | $330K |
| 12 | MDT | MEDTRONIC PLC | 2.58% | 2,976 | $266K |
| 13 | UCB.BR | UCB SA | 2.48% | 1,193 | $255K |
| 14 | ACAD | ACADIA PHARMACEUTICALS, INC. | 2.42% | 10,596 | $249K |
| 15 | AXSM | AXSOME THERAPEUTICS, INC. | 2.33% | 2,327 | $240K |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — | ||
| 1W | — | — | ||
| 1M | — | — | ||
| 3M | — | — | ||
| 6M | — | — | ||
| YTD | — | — | ||
| 1Y | -0.69% | — | ||
| 3Y | -6.63% | — | ||
| 5Y | -6.63% | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
$24.55
Current Price
—
52-Week Low
$20.12
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | MNTL | Healthcare(223 ETFs) | Active(633 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.75% | 0.60% | 0.80% |
| AUM | $10.3M | $1.24B | $313.3M |
| Dividend Yield | — | 2.75% | 6.33% |
| Avg Volume | — | 800.9K | 194.9K |
| Holdings | 4 | 171 | 85 |
| Performance | |||
| 1-Month Return | — | -4.57% | -2.59% |
| 6-Month Return | — | +4.90% | -2.60% |
| YTD Return | — | -1.70% | -1.35% |
| 1-Year Return | — | +15.18% | +6.28% |
Compare with Another ETF
Search for an ETF to compare with MNTL: